BEAM:NASDAQ
Beam Therapeutics Inc
$26.30
arrow_downward
-0.79%(-0.21) 1D
Aug 14, 12:21:13 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
$26.64
High
$26.64
Low
$25.71
Mkt. cap
2.72B
Avg. vol.
2.12M
Volume
598.18K
52-wk high
$38.26
52-wk low
$15.60
EPS
-$0.81
Beta
2.23
Shares outstanding
103.29M
No. of employees
540
Open
$26.64
High
$26.64
Low
$25.71
Mkt. cap
2.72B
Avg. vol.
2.12M
Volume
598.18K
52-wk high
$38.26
52-wk low
$15.60
EPS
-$0.81
Beta
2.23
Shares outstanding
103.29M
No. of employees
540
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc
AI content may include mistakes. Learn more